Filing Details
- Accession Number:
- 0001213900-19-016453
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-21 16:33:04
- Reporting Period:
- 2019-08-20
- Accepted Time:
- 2019-08-21 16:33:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1711754 | Inmune Bio Inc. | INMB | Biological Products, (No Disgnostic Substances) (2836) | 475205835 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1767280 | Joseph Raymond Tesi | C/O Inmune Bio Inc., 1200 Prospect Street, Suite 525 La Jolla CA 92037 | President & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-08-20 | 100 | $5.96 | 1,539,033 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-20 | 100 | $5.96 | 1,539,133 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-20 | 100 | $5.96 | 1,539,233 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-20 | 100 | $5.96 | 1,539,333 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-20 | 100 | $5.96 | 1,539,433 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-20 | 100 | $5.96 | 1,539,533 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-20 | 100 | $5.96 | 1,539,633 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-20 | 100 | $5.96 | 1,539,733 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-20 | 100 | $5.96 | 1,539,833 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-20 | 100 | $5.92 | 1,539,933 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-20 | 1,000 | $6.03 | 1,540,933 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions.